Has Mona Foad, MD received payments from drug or device companies?

Yes. Drug and device makers reported $212,492 in general payments to Mona Foad, MD across 570 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mona Foad, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mona Foad, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mona Foad, MD

Dermatology · Cincinnati, OHNPI 1316011661

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $169,873 of the $212,492 with a category attached, or 79.9%. AbbVie accounts for 98.7% of it on its own, with 23 other manufacturers making up the rest. Among dermatology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$212,492in general payments, 2019–2025

Across 570 payments — averaging $372.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$210K
Novartis$555
Pfizer$357
Sun Pharmaceutical Industries Inc.$304
E.r. Squibb & Sons, L.L.C.$282
Johnson & Johnson$212
plus $1K from 18 others

What the payments were for

Consulting fees$12,9436%
Speaking & faculty fees$169,87380%
Travel & lodging$15,7617%
Food & beverage$13,6636%
Education$2520%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	406	$209,701
Novartis	27	$555
Pfizer	37	$357
Sun Pharmaceutical Industries Inc.	12	$304
E.r. Squibb & Sons, L.L.C.	28	$282
Johnson & Johnson	10	$212
Galderma Laboratories, L.p.	5	$149
UCB, Inc.	7	$132
Merz North America, Inc.	3	$128
Incyte Corporation	4	$90
LEO Pharma Inc.	6	$88
Lilly USA, LLC	4	$85
VYNE Pharmaceuticals Inc.	1	$79
Bristol Myers Squibb	3	$48
Arcutis Biotherapeutics, Inc.	3	$47
Sanofi	2	$47
Mayne Pharma Commercial LLC	3	$42
Biofrontera Inc.	2	$33
Strata Skin Sciences, Inc.	2	$24
Verrica Pharmaceuticals Inc.	1	$22
Dermira, Inc.	1	$21
Regeneron Healthcare Solutions, Inc.	1	$19
Almirall LLC	1	$14
Amgen	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BOTOX$68,730
KYBELLA$1,950
COSENTYX$120

How this compares

$212,492 in reported general payments places this provider in the 95th percentile of 460 dermatology providers in Ohio.

See all dermatology providers in Ohio →

Medicare billing

Part B allowed, 2024

$287,771

Medicare patients

867

Services billed

6,013

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metronidazole	24	$1,614
Azelaic Acid	16	$1,403
Doxycycline Hyclate	12	$501
ValacyclovirValacyclovir Hcl	44	$490
Ketoconazole	28	$314
Triamcinolone Acetonide	34	$250
Hydrocortisone	33	$188
Mupirocin	22	$180
ErythromycinErythromycin Base In Ethanol	11	$169
Azithromycin	24	$103
Terbinafine Hcl	13	$49
Prednisone	24	$44

Paid to pharmacies, not to this prescriber.

Other dermatology in Cincinnati

Alan FleischerCincinnati$34K
Matthew ZirwasBexley$3.3M
George DrewMarion$1.9M
Rocco SerraoDayton$1.7M
James LibeccoFairlawn$1.1M
Pranav ShethWest Chester$978K
Dawn MerrittAthens$844K
Neil KormanCleveland$824K
Joshua GrosshandlerWesterville$479K
Lorie GottwaldToledo$460K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →